FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs
Friday, 13 September 2019
The FDA tested ranitidine heartburn medications and found small amounts of a probable carcinogen. The agency has not recommended the drugs be recalled
You Might Like
Recent related videos from verified sources
FDA: No Carcinogens In OTC Heartburn Meds
Zantac and its generic versions, known chemically as ranitidine, are popular heartburn medicines.
Reuters reports they have not been found to contain the carcinogen that ranitidine has been linked..
Credit: Wochit Duration: 00:46 Published 2 hours ago
Pharmacy Chains Pull Heartburn Drug Zantac From Shelves
In September, the Food and Drug Administration warned that a heartburn drug may contain a cancer-causing chemical.
Over the weekend, the chain pharmacy CVS announced it would stop selling all versions..
Credit: Wochit Duration: 00:36 Published 3 weeks ago